Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Luvera Law Firm: Judge Awards $15.2 million after Doctors' Miscue Leaves Child Brain Damaged

University of Washington and Seattle Children's doctor recommends wrong medication for a 4-year-old girl leading to cardiac arrest and severe brain damage


News provided by

Luvera Law Firm

Jul 12, 2013, 02:36 ET

Share this article

Share toX

Share this article

Share toX

SEATTLE, July 12, 2013 /PRNewswire/ -- A judge today has awarded an 8-year-old girl from Snoqualmie, Wash. $15.2 million after a University of Washington doctor at Seattle Children's Hospital improperly recommended an over-the-counter medication that left the child with permanent brain damage.

The case, filed Oct. 28, 2011 in King County Superior Court, alleged that the University of Washington and Seattle Children's Hospital committed medical negligence.

MacKenzie Briant – who had undergone a heart transplant as an infant – was given a dose of Afrin at the direction of a cardiologist, which caused the cardiac event, depriving her brain of oxygen and leading to extensive brain damage.

According to court records, MacKenzie's mother Elaine Briant called Seattle Children's Transplant Service – where MacKenzie received care – because MacKenzie had developed a cold and stuffy nose.  The mother's call was returned by Dr. Cory Noel, a cardiology fellow who was working in the Transplant Service.  

Court records show that Noel then spoke to transplant cardiologist Dr. Yuk Law, who provided treatment suggestions to Noel and specifically warned that MacKenzie should not be given Afrin, a decongestant, because it could cause hypertension or other cardiac issues.

Dr. Noel misunderstood, and instead directed MacKenzie's mother to give the child Afrin – exactly opposite of what he was instructed. Within minutes after receiving Afrin, MacKenzie suffered a cardiac arrest.

Paramedics arrived and re-started her heart, but not before her brain was starved of oxygen, causing irreparable brain damage. MacKenzie spent nearly two months in Seattle Children's Hospital before she was released. She now requires around-the-clock nursing care.

"In all my years representing families dealing with medical malpractice, this is one of the most heartbreaking medical negligence cases I have seen," said Ralph Brindley, partner of The Luvera Law Firm and the attorney representing the Briant family. "When we talk about medical errors, rarely is the error as elementary and vivid as failing to verify and follow a verbal order, especially as simple as something like 'do not use Afrin.'"

Brindley noted that had Noel repeated Law's order back to him -- standard procedure in healthcare – Law would most certainly have corrected Noel's error.

"Tragically, Dr. Noel did not follow the procedures to deliver an acceptable standard of care, and as a result, MacKenzie will spend the rest of her life unable to speak or feed herself."

MacKenzie was born in 2004 with a congenital heart defect and received a heart transplant at 110 days-old. Since that transplant, MacKenzie had blossomed into a vibrant child, enrolled in school, and was in good health, according to court documents.

In November 2008, one month after her fourth birthday, MacKenzie had a cold with typical symptoms, including nasal congestion. Her primary care pediatrician diagnosed MacKenzie with an upper respiratory infection. Elaine Briant kept in close contact not only with him, but with the hospital over the next several days.

According to court documents, Elaine Briant called Seattle Children's Hospital looking for a recommendation to relieve MacKenzie's nasal congestion. Dr. Noel returned her call, retrieved the appropriate information from her and consulted with Dr. Law, who has treated MacKenzie for years. Dr. Noel's recommendation was that Elaine Briant should treat her daughter with Afrin.

Afrin, like many nasal decongestants, is a vasoconstrictor, which can cause increased blood pressure, which puts unnecessary stress on the heart for vulnerable pediatric heart-transplant patients. "The medical literature is clear – giving a heart-transplant patient a dose of Afrin is unacceptable," Brindley added.

Dr. Noel testified that he does not know where the miscommunication took place, but that he had directed Mrs. Briant to give Afrin to MacKenzie – even though Dr. Law testified he told him not to. Several minutes later MacKenzie went into cardiac arrest and stopped breathing. Emergency Services resuscitated MacKenzie and took her to Seattle Children's Hospital.

MacKenzie stayed at the hospital for nearly two months, including a month in the ICU, until she was released Jan. 16, 2008, diagnosed with severe brain damage.

The three-week bench trial began on April 22, 2013. Judge John Erlick issued his ruling today.

"This was an incredibly hard-fought case," said Brindley. "While the University of Washington and Seattle Children's finally admitted its doctors were negligent, they steadfastly argued that the Afrin was not the cause of MacKenzie's cardiac event, although she coded soon after her mother administered the dose. We are enormously grateful that Judge Erlick reached the conclusions he did."

The family cares for MacKenzie twenty-four hours a day with the help of nurses, when available. MacKenzie, now 8-years-old, also has a 12-year-old brother.

"While we are obviously devastated about this medical error, we want to be clear that we do not hold Dr. Law in any way responsible for this tragedy," Elaine Briant added. "He gave the appropriate information to Dr. Noel, and I know he shares our grief."

Briant noted that Dr. Law continues to be MacKenzie's cardiologist.

About Luvera Law Firm
Luvera Law Firm is a nationally recognized firm, with high standards of ethical conduct. The firm specializes in medical malpractice, brain injury, death and other major damage cases, and seeks justice for clients as well as positive changes in corporate and governmental behavior.  Two members of the firm belong to the Inner Circle of Advocates, the nation's most exclusive plaintiff's trial lawyer's association, whose membership is limited to 100 of the best lawyers in the United States.

CONTACTS:
Ralph Brindley [(206) 467-6090]
Luvera Law Firm
[email protected]

SOURCE Luvera Law Firm

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.